Corcept Therapeutics

CORT

4 Followers

$71.38

+1.31%

$0.92

4 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

CORT Fair Price

$43.74

Overvalued by 4.8%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Corcept Therapeutics Incorporated (CORT) is an American biotechnology company specializing in research, development, and commercialization of drugs for the treatment of endocrine and psychiatric disorders. With activities in biotechnology and pharmacology, Corcept Therapeutics is a key player in the world of innovative treatment approaches. Their research focuses on discovering new treatment methods and therapies for patients with endocrine and psychiatric disorders, including Cushing's syndrome. The company aims to provide modern treatment solutions and improve the quality of life for patients. Corcept Therapeutics is characterized by expertise in pharmacology and endocrine medicine. Corcept Therapeutics Incorporated (CORT) shares could be suitable for investors looking for an investment opportunity in the biotechnology and pharmaceutical sector with a company that specializes in innovative treatment approaches and therapies for patients with endocrine and psychiatric disorders.

Feed

There are no posts to show right now.